TOP - October 2011 Vol 4, No 7

WASHINGTON, DC—Psychosocial stress may play a role in the etiology of breast cancer aggressiveness, particularly among minority populations, according to study results. In a cross-sectional study, greater levels of fear, anxiety, or isolation were found to be associated with more aggressive breast cancer; however, no clear driver for the association is yet identified.

TOP - October 2011 Vol 4, No 7 published on October 20, 2011 in Reader Survey

In the September issue, we published an article entitled Patients Want to Discuss Cost of Cancer Care, Oncologists Often Avoid It. We wondered if patients were talking to their pharmacists about the cost of their oncology drugs.

Here’s how our online reading community responded:

  • 14%indicated they are never asked about drug costs
  • 48%said patients occasionally talk to them about drug costs
  • 38% are regularly talking with patients about drug costs
TOP - October 2011 Vol 4, No 7 published on October 20, 2011 in Supportive Care

Many cancer survivors who thought they were fertile now may be finding that is not the case. New research is suggesting that current estimates of the impact of chemotherapy on women’s reproductive health are too low.

Researchers at the University of California San Francisco (UCSF) say their analysis of the age-specific, longterm effects of chemotherapy provides new insights that will help patients and clinicians make more informed de cisions about future reproductive options, such as egg harvesting (Cancer. September 1, 2011. Epub ahead of print).

TOP - October 2011 Vol 4, No 7 published on October 20, 2011 in Koeller's Corner

I will admit that I am knowingly and willingly walking into a hornet’s nest by discussing the current drug shortage, but I feel I must. In addition to our (oncology pharmacists’) ruminations about the current drug shortage, the issue has garnered national media attention. Major newspapers, national TV networks, magazines, and numerous websites have jumped on the drug shortage story.

TOP - October 2011 Vol 4, No 7 published on October 20, 2011 in Oral Oncolytics
Oral chemotherapeutic agents have transformed the management of cancer treatment— transitioning the primary location of care to the ambulatory setting and providing patients with a convenient, noninvasive option to manage their malignancy.
TOP - October 2011 Vol 4, No 7 published on October 20, 2011 in Breast Cancer
Bevacizumab (Avastin; Genentech) for metastatic breast cancer may be one of the most widely debated, media-reported, and editorialized agents in oncology.
WASHINGTON, DC—The overall incidence of breast cancer is generally higher among white women than black women. The incidence of a second breast cancer in the opposite breast, however, is higher among black women, according to new data.

SAN FRANCISCO—A number of interventions can help reduce breast cancer among women at high risk, but uptake is sluggish, and there can be confusion about which agent to prescribe to a given patient. Seema Khan, MD, professor of surgery at Northwestern University Feinberg School of Medicine, Chicago, addressed the topic of pharmacologic risk reduction at the 2011 Breast Cancer Symposium.

Page 2 of 2
Results 11 - 18 of 18